Viva Biotech (Shanghai) Ltd. is a high-tech company specializing in innovative drug R&D services. It was established in 2008, with a registered capital of 25 million USD. Headquartered in Shanghai Zhangjiang Hi-tech Park, it now has become the famous cradle of global new drug R&D startup companies.
The company’s principal businesses include research and development of biomedical technology and biological products and transfer of its self-developed R&D results. Its technology export projects are mainly biotechnology R&D services, including providing R&D services from gene to protein or protein structure; offering screening service of drugs at the cellular and molecular levels; supplying R&D service of membrane protein; providing affinity mass spectrometry screening service based on mass spectrum, etc. Currently, the company is in the leading position globally in many technological fields, such as protein structure research technology, membrane-based new drug R&D technology, fragment-based compound new drug R&D technology, and structure-based new drug R&D service, etc.
With the development of the company’s businesses, Viva Biotech’s global reputation has been greatly enhanced. With the structure-based new drug R&D technology as its core, Viva Biotech is now the largest structure-based new drug R&D platform in the world. It has established long-term R&D cooperation with nearly 300 pharmaceutical companies and biotechnology companies, including the world's top ten pharmaceutical companies. Among them, 85% are from Europe and the US. It provides world leading structure-based drug discovery services for innovative drug development in preclinical stages for global biotech and pharmaceutical clients, which cover customer’s comprehensive demands for early drug discovery, including target protein expression and structure research, drug screening, in vitro activity testing of compounds, structural optimization of target compounds and lead compounds, and determination of the clinical candidate compounds.
At present, Viva Biotech has nearly 500 employees, including 2 experts of the national "Thousand Talents Program" and 3 experts of Shanghai "Thousand Talents Program". Among them, doctors take up 10%. Most of them are from the US, who have more than 15 years' working experience in large foreign pharmaceutical companies. Meanwhile, the company has obtained 4 global patent authorizations and 10 Chinese invention patents. It has won certificates such as Advanced Technology Service Enterprise, Offshore Entrepreneurship and Innovation Base for Overseas Talents, etc.
Viva Biotech is the only high-tech group in the world that takes creating biomedical technology enterprise as its responsibility. At present, there are 21 biomedical innovation enterprises invested and incubated by Viva Biotech, and their R&D projects are leading globally in their own fields.